Table 3.
Tests for SARS-CoV-2 infection and future directions
| Responders | ||
|---|---|---|
| Number | Percent | |
| Q17. Is there a policy for screening patients with cancer for SARS-CoV-2 infection (without any symptoms) | ||
| A. Yes, they are screened once | 12 | 17.6% |
| B. Yes, they are screened several times | 16 | 23.5% |
| C. Yes, they are screened, and their family members are as well | 12 | 17.6% |
| D. No, they are not screened at all | 28 | 41.2% |
| Q18. What do you recommend for cancer patients diagnosed with COVID-19? | ||
| A. Total quarantine, time undefined | 3 | 4.4% |
| B. Delay all treatments for several weeks until cleared for treatment by specialist | 31 | 45.6% |
| C. Continue treatment (if cancer is aggresive and patient is asymptomatic) | 34 | 50% |
| Q22. What is your approach to patients who live in “endemic” regions? | ||
| A. Continue with regular precaution (surgical mask) no COVID-19 exam is needed | 21 | 31% |
| B. Continue treatment but use extra precaution (N95 mask/eye shield /plastic covers) | 19 | 28% |
| C. Have one sample that confirms that no active infection is present | 5 | 7.4% |
| D. Multiple samples on different time should be made during the radiation course | 11 | 16% |
| E. Not applicable | 12 | 17.6% |
| Q10. At the present time are tests for SARS-CoV-2 infection available (may answer several options) | ||
| A. Yes, tests are performed for all patients and staff | 4 | 5.9% |
| B. Yes, tests are performed upon request | 12 | 17.6% |
| C. Tests are performed only if fulfilled predetermined criteria | 49 | 72% |
| D. Only for symptomatic cases who were in contact with a known COVID-19 carrier | 12 | 17. 6% |
| E. No tests are available, only for cases admitted to intensive care unit | 1 | 1.5% |
| Q23. At you institute who is responsible for informing the department of the tests results of SARS-CoV-2 during a course of radiation treatment | ||
| A. The patient himself/herself | 12 | 17.6% |
| B. The health care authorities | 11 | 16.2% |
| C. The hospital where I work | 34 | 50% |
| D. I do not know | 11 | 16% |
| Q24. At you institute how is information of the SARS-CoV-2 infection of your patients during radiation transmitted? | ||
| A. The information in given in fast and effective way | 44 | 64.7% |
| B. Information in given after several days, but I will defenitly be informed | 12 | 17.6% |
| C. Information may not be available to us | 4 | 6% |
| D. I do not know | 8 | 11.8% |
| Q25. Did your institute prepare a plan for the period after the COVID-19 outbreak subsides? | ||
| A. Yes. We have concrete planes and made lists of patients that are on “waiting lists” | 26 | 39% |
| B. We discussed this but only in general ideas | 27 | 40% |
| C. I do not think this was discussed | 14 | 21% |